Ethema Health (OTCMKTS:GRST) versus Embecta (NASDAQ:EMBC) Head to Head Analysis

Ethema Health (OTCMKTS:GRSTGet Free Report) and Embecta (NASDAQ:EMBCGet Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

Risk & Volatility

Ethema Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Embecta has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Ethema Health and Embecta, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ethema Health 0 0 0 0 0.00
Embecta 0 4 0 0 2.00

Embecta has a consensus target price of $18.50, suggesting a potential upside of 374.36%. Given Embecta’s stronger consensus rating and higher probable upside, analysts plainly believe Embecta is more favorable than Ethema Health.

Profitability

This table compares Ethema Health and Embecta’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ethema Health -9.35% N/A -5.77%
Embecta 12.92% -26.66% 16.06%

Earnings & Valuation

This table compares Ethema Health and Embecta”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ethema Health $6.02 million 0.00 -$2.06 million N/A N/A
Embecta $1.08 billion 0.21 $95.40 million $2.37 1.65

Embecta has higher revenue and earnings than Ethema Health.

Institutional & Insider Ownership

93.8% of Embecta shares are held by institutional investors. 55.8% of Ethema Health shares are held by insiders. Comparatively, 1.3% of Embecta shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Embecta beats Ethema Health on 8 of the 10 factors compared between the two stocks.

About Ethema Health

(Get Free Report)

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.

About Embecta

(Get Free Report)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Receive News & Ratings for Ethema Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ethema Health and related companies with MarketBeat.com's FREE daily email newsletter.